机译:从总血浆浓度的估算估算总血浆浓度作为促进治疗药物监测的方法
IUCT Oncopole Inst Claudius Regaud Toulouse France;
IUCT Oncopole Inst Claudius Regaud Toulouse France;
Univ Paris Saclay Inst Gustave Roussy Pharmacol Dept Villejuif France;
CHU Lyon Lab Pharmacol &
Toxicol Lyon France;
CHU Angers Lab Pharmacol &
Toxicol Angers France;
CHU La Timone Marseille France;
IUCT Oncopole Inst Claudius Regaud Toulouse France;
Inst Gustave Roussy Med Oncol Dept Villejuif France;
Ctr Leon Berard Lyon France;
Inst Cancerol Ouest Paul Papin Angers France;
Inst Paoli Calmettes Marseille France;
Tenon Hosp Paris France;
CHU Clermont Ferrand Clermont Ferrand France;
Hop St Andre Bordeaux France;
CHU Lyon Lab Pharmacol &
Toxicol Lyon France;
IUCT Oncopole Inst Claudius Regaud Toulouse France;
IUCT Oncopole Inst Claudius Regaud Toulouse France;
IUCT Oncopole Inst Claudius Regaud Toulouse France;
IUCT Oncopole Inst Claudius Regaud Toulouse France;
unbound carboplatin; therapeutic drug monitoring; high-dose chemotherapy; estimation; total plasma carboplatin concentration;
机译:从总血浆浓度的估算估算总血浆浓度作为促进治疗药物监测的方法
机译:芽总和未结合的Teicoplanin浓度的变异性和成年血液恶性肿瘤患者治疗药物监测靶标的变异性
机译:β-内酰胺抗生素的治疗药物监测在批判性病中:直接测量未结合的药物浓度,以达到适当的药物曝光
机译:高效磷脂去除清洁SPE-LC-MS / MS法,用于同时血浆定量11酪氨酸激酶抑制剂和咖啡因。应用于治疗药物监测
机译:同时测定生物活性化合物的自由浓度,总浓度和血浆结合能力
机译:成年血液恶性肿瘤患者低谷总和未结合替考拉宁浓度的变异性和治疗药物监测目标的实现
机译:成年血液恶性肿瘤患者谷中总和未结合替考拉宁浓度的变化和治疗药物监测目标的实现